Understanding Margin Status in Pathology Reports
When a tissue sample is removed for cancer, whether during surgery, biopsy, or excision one…
Latest Articles
Read MoreUnderstanding Margin Status in Pathology Reports
Understanding Rare Cancers and How They Are Diagnosed
Cancer is not a single disease. While many people are familiar with common cancers like…
Understanding the Difference Between In-Situ and Invasive Carcinoma
The distinction between in-situ and invasive carcinoma is one of the most important concepts in…
How Liquid Biopsies Detect Cancer Changes
Liquid biopsies analyze cancer-related material circulating in the blood, most commonly circulating tumor DNA, sometimes…
How to Understand Immunohistochemical Findings in Cancer Pathology Reports
Immunohistochemistry, often abbreviated as IHC, is one of the most important yet confusing sections of…
How to Explain a Cancer Pathology Report to Family Members
A cancer diagnosis rarely affects just one person. Family members often become caregivers, advocates, and…
How Cancer Recurrence Is Detected in Pathology and What Patients Need to Know
Few words in cancer care carry as much emotional weight as “recurrence.” For many patients,…
How Pathology Reports Influence Clinical Trial Eligibility
Clinical trials are often described as the engine that drives medical progress. For many patients,…
What Biomarkers Mean in Cancer Reports and Why They Matter More Than Eve
If you’ve ever opened a cancer pathology report and felt overwhelmed by unfamiliar terms, you…
